POLY MEDICURE
|
The Current P/E Ratio of POLY MEDICURE is 57.64.
| Share Price | ₹1,998.4 | Oct 31,2025 |
| Market Cap | ₹20,263.8 Cr | |
| Earnings-TTM | ₹351.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 57.64x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of POLY MEDICURE
Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹20,263.8 Cr] as on Oct 31,2025
(/) Earnings [ ₹351.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 57.64x ]
P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.
Thus, for POLY MEDICURE , the investors are currently willing to pay 57.64 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of POLY MEDICURE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of POLY MEDICURE over the last five years.
Thus, for POLY MEDICURE , the investors are currently willing to pay 57.64 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of POLY MEDICURE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of POLY MEDICURE over the last five years.
Historical PE (Price/Earnings) ratio chart of POLY MEDICURE
PE Ratio Performance Analysis for POLY MEDICURE
- POLY MEDICURE 's latest p/e ratio is 57.64x.
- POLY MEDICURE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 59.39x.
- POLY MEDICURE 's operated at median p/e ratio of 59.04x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, POLY MEDICURE 's p/e ratio peaked in Mar2025 at 67.1x.
- POLY MEDICURE 's p/e ratio hit its five-year low in Mar2023 of 51.01x.
- POLY MEDICURE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 59.39x.
- POLY MEDICURE 's operated at median p/e ratio of 59.04x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, POLY MEDICURE 's p/e ratio peaked in Mar2025 at 67.1x.
- POLY MEDICURE 's p/e ratio hit its five-year low in Mar2023 of 51.01x.
How does POLY MEDICURE 's P/E Ratio benchmark against top 10 peers in Medical Equipment/Supplies/Accessories Industry?
| Peer Comparison (Medical Equipment/Supplies/Accessories Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| POLY MEDICURE | 351.53 | 57.64 | 20,263.8 |
| NURECA LTD | 4.11 | 64.06 | 263.0 |
Medical Equipment/Supplies/Accessories Industry Benchmark (Top 10) PE Analysis vs POLY MEDICURE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 57.64x |
| Max industry PE | 64.06x |
| Median industry PE | 64.06x |
| Average industry PE | 60.85x |
You may also like the below Video Courses
